Financial Health Assessment: WILLIAM & A.M. ROBB LIMITED

1. Financial Health Score: C+

The patient is stable but exhibiting chronic symptoms of decline. While the company maintains strong liquidity and solvency — with no immediate threat of insolvency — there is a persistent, multi-year deterioration in net assets that requires attention. The significant loss in the most recent year (£152,877 erosion in retained earnings) represents an acute episode that cannot be ignored.

2. Key Vital Signs

Long-Term Net Asset Trajectory (10-Year View)

Overall decline from peak (2017): £420,643 or 35.0%

3. Diagnosis

Primary Condition: Chronic Net Asset Erosion with Acute Investment Depreciation

The financial data reveals a business suffering from a long-term, progressive condition. Like a patient with slowly declining vitality, the company has lost over a third of its net worth from its 2017 peak.

Symptom Analysis

1. The Investment Portfolio is the Heart of the Problem

The company's balance sheet is dominated by investments (£709,675), representing approximately 74% of total assets. This is an unusually high concentration that makes the company's financial health heavily dependent on investment performance. The £127,417 decline in investments between 2024 and 2025 is the primary driver of the overall asset reduction.

Think of this as a patient whose cardiovascular health depends almost entirely on one organ — when that organ falters, the entire system suffers.

2. Retained Earnings Haemorrhage

The drop in retained earnings from £437,625 to £284,748 represents a loss of £152,877. With no dividends declared (share capital and other reserves unchanged), this indicates the company incurred a substantial trading or investment loss during the year.

3. Cash Flow Under Pressure

Cash has declined from a 2017 peak of £191,125 to just £64,338 — a 66.4% reduction over eight years. While the company still maintains positive cash, the trajectory suggests the business may be consuming cash to fund operations or investment losses.

4. Rising Liabilities and Provisions

Current liabilities have risen 37% since 2017 (£59,525 → £91,772), and provisions have increased to £79,091. This suggests the company is deferring more obligations and anticipating future costs — a symptom of financial stress.

5. Operating in a Challenging Sector

As a textile wholesaler (SIC 46410), the company operates in a mature, often declining sector facing competitive pressures from overseas manufacturing and changing retail patterns.

Positive Vital Signs (Mitigating Factors)

• Strong Liquidity: Current ratio of approximately 10:1 (current assets of £917,144 vs. current liabilities of £91,772) — exceptionally healthy
• Quick Ratio: Approximately 9.3:1 excluding stock — robust short-term solvency
• Low Leverage: Total liabilities of £170,863 against equity of £782,529 gives a debt-to-equity ratio of just 0.22:1 — minimal debt burden
• Long Heritage: Incorporated in 1941, the business has survived 83+ years, demonstrating resilience
• No Overdue Filings: Compliance is current — the patient is keeping appointments
• Stable Workforce: Maintained 6 employees consistently

4. Prognosis

Short-Term (12 months): Stable but Vulnerable

The company is not at risk of insolvency in the near term. Liquidity is strong, and liabilities are manageable. However, continued investment losses could rapidly deteriorate the position.

Medium-Term (2-5 years): Cautious Concern

If the current trajectory continues — with net assets declining by 10-20% per year — the company could see its equity base erode to concerning levels within 3-4 years. The 2020 dip (likely COVID-related) showed the company can recover, but the 2025 decline is more alarming because it follows two years of already declining performance.

Key Risk: Investment Portfolio Concentration

With 74% of assets in investments, the company's financial health is disproportionately exposed to market conditions and investment performance. Any further significant decline could push the company into a precarious position.

5. Recommendations

Immediate Actions (Urgent)

1. Investment Portfolio Review 🔴 - Conduct a thorough review of the £709,675 investment portfolio - Assess whether losses are unrealized (fair value adjustments) or realized (actual disposals at a loss) - Consider diversification to reduce concentration risk - Evaluate whether investment strategy aligns with the company's risk appetite and operational needs

2. Cash Flow Management 🔴 - With cash at £64,338 and declining, implement tighter cash flow forecasting - Review whether investments can be partially liquidated to bolster cash reserves - Consider establishing a minimum cash threshold (e.g., £50,000) as a financial "safety net"

Medium-Term Actions (Important)

3. Trading Performance Review 🟡 - The retained earnings decline suggests either trading losses or investment losses flowing through P&L - Conduct a detailed profitability analysis by product line/customer segment - Consider whether the core wholesale textiles business is viable at current scale

4. Provisions Assessment 🟡 - The £79,091 in provisions should be reviewed — are these necessary, or can they be released? - Understand what future costs are being anticipated and whether they can be mitigated

5. Strategic Direction 🟡 - Given the sector challenges, consider whether diversification, partnership, or strategic pivot is needed - Evaluate whether the business model needs modernisation (e-commerce, niche specialisation)

Long-Term Actions (Preventative)

6. Succession Planning 🟢 - With three family members as PSCs (each owning 25-50%), ensure clear succession and governance arrangements - Consider whether all three shareholders are actively involved and aligned on strategy

7. Capital Preservation Strategy 🟢 - Develop a formal policy for investment risk management - Consider whether the investment portfolio should be reduced and funds held in lower-risk instruments

Summary Dashboard